These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2895747)

  • 1. Effects of AHR-5333, a new potential antiallergy compound, in in vivo models of immediate hypersensitivity.
    Yanni JM; Foxwell MH
    Int Arch Allergy Appl Immunol; 1988; 85(4):428-33. PubMed ID: 2895747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vivo and in vitro activity of AHR-13268D, a new antiallergic/antihistaminic agent.
    Nolan JC; Foxwell MH; Whitman LL; Johnson DN; Yanni JM; Greene SV
    Agents Actions; 1990 Nov; 31(3-4):210-8. PubMed ID: 1982201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
    Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levocabastine: pharmacological profile of a highly effective inhibitor of allergic reactions.
    Awouters F; Niemegeers CJ; Jansen T; Megens AA; Janssen PA
    Agents Actions; 1992 Jan; 35(1-2):12-8. PubMed ID: 1354927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiallergy activity of 4-(diarylhydroxymethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Walsh DA; Franzyshen SK; Yanni JM
    J Med Chem; 1989 Jan; 32(1):105-18. PubMed ID: 2562852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BL-5255, a tetrazolylpyrimidinone with potent oral antiallergy activity in animals.
    Siminoff P; Reed FC; Schurig JE; Juby PF
    Monogr Allergy; 1979; 14():318-23. PubMed ID: 91959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine.
    Nolan JC; Stephens DJ; Proakis AG; Leonard CA; Johnson DN; Kilpatrick BF; Foxwell MH; Yanni JM
    Agents Actions; 1989 Aug; 28(1-2):53-61. PubMed ID: 2571244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
    Ueno M; Inagaki N; Nagai H; Koda A
    Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
    Evans DP; Thomson DS
    Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators.
    Awouters F; Niemegeers CJ; Van den Berk J; Van Neuten JM; Lenaerts FM; Borgers M; Schellekens KH; Broeckaert A; De Cree J; Janssen PA
    Experientia; 1977 Dec; 33(12):1657-9. PubMed ID: 22455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator and antiallergic effects of thiazinamium chloride in guinea pigs, rats, cats and dogs.
    Lewis AJ; Dervinis A; Rosenthale ME
    Eur J Pharmacol; 1982 May; 80(2-3):171-84. PubMed ID: 6125398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies on the novel antiallergic drug HQL-79: I. Antiallergic and antiasthmatic effects in various experimental models.
    Matsushita N; Hizue M; Aritake K; Hayashi K; Takada A; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
    Jpn J Pharmacol; 1998 Sep; 78(1):1-10. PubMed ID: 9804056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of immediate hypersensitivity reaction by a new drug, RU-31156.
    Koda A; Nagai H; Sato N; Nakatomi I; Nishiyori T; Mori H; Inagaki N
    J Pharmacol; 1984; 15(3):353-73. PubMed ID: 6208430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway closure after antigen challenge in cynomolgus monkeys: effect of the histamine H1 receptor antagonist, chlorpheniramine maleate.
    Skeans S; Lamca JE; House A; Celly CS; Hey JA; Chapman RW
    Int Arch Allergy Immunol; 2005 May; 137(1):37-44. PubMed ID: 15785080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiallergy properties of U-17,660, a dibenzodiazepine.
    Greig ME; Gibbons AJ; Young GA
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):299-308. PubMed ID: 4396925
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.